Investigators questioned whether cognitive tests could predict driving ability in people with Alzheimer disease and mild cognitive impairment.
Alisa G. Woods, PhD
New research in a mouse model could have implications for recovery of function in individuals who have suffered more than one stroke.
By studying first-degree relatives of patients with MS, can researchers perfect a risk algorithm for the disease?
A groundbreaking discovery may lead to repair of neurodegenerative diseases such as Alzheimer and Parkinson.
The discovery of a possible trigger for PD and Lewy body dementia could provide a new avenue for gene therapy in these neurological conditions.
A recent webinar summarized on-going efforts to halt Parkinson disease, including several phase III trials.
Research findings indicate that signs of Alzheimer may begin earlier than previously thought and genotyping could identify those at risk.
Dysregulated dopamine may not be the sole cause of impulse control problems in patients with Parkinson disease.
Researchers studied type 2 diabetes-induced neurodegeneration and the possible link to Alzheimer disease.
Dopamine may not be the only neurotransmitter affected in Parkinson disease.